Pediatric and Primary Lymphedema (PPL-WG)
Clinical Expert Consensus Statements Written
The Pediatric and Primary Lymphedema Working Group (PPL-WG) have developed consensus statements drawing from the latest research and clinical data to provide evidence-based recommendations for the diagnosis, treatment and management of these diseases.
The PPL-WG is currently working on the production of consensus statement documents on various topics including diagnostic patient pathway for PPL, QoL for children, compression in children.
Results (3)
COVID-19 (Coronavirus) Richtlinien für die Gemeinschaft der Lymphgefäßkrankheiten
March 30 2023
The Pediatric and Primary Lymphedema (PPL) Working Group endorses the COVID-19 statement by the Lymphoedema Support Network
VASCERN Pediatric and Primary Lymphedema (PPL) Working Group – Statement concerning SARS-CoV-2 vaccination for patients with lymphedema
March 09 2023
COVID-19 statement by the Lymphoedema Support Network
March 09 2023
The Pediatric and Primary Lymphedema (PPL) Working Group endorses the COVID-19 statement by the Lymphoedema Support Network.